Skip to main content
. 2021 Aug 2;78(9):1–9. doi: 10.1001/jamaneurol.2021.2385

Table 1. Baseline Characteristics of the Modified Intention-to-Treat Populationa.

Characteristic Patients, No. (%)
DTAS (n = 74) DTCT (n = 73)
Age, mean (SD), y 71.8 (13.1) 75.6 (12.3)
Sex
Male 38 (51.4) 32 (43.8)
Female 36 (48.6) 41 (56.2)
Prestroke mRS score, median (IQR)b 1 (0-1) 1 (0-1)
Prestroke mRS score
0 26 (35.1) 22 (30.1)
1 31 (41.9) 36 (49.3)
2 14 (19.4) 14 (19.2)
>2 3 (4.1) 1 (1.4)
Risk factors
Hypertension 56 (75.7) 46 (63.0)
Diabetes 10 (13.5) 19 (26.0)
Dyslipidemia 31 (41.9) 38 (52.1)
Atrial fibrillation 21 (28.4) 23 (31.5)
Previous stroke 12 (16.2) 9 (12.3)
Ischemic heart disease 11 (14.9) 15 (20.5)
Current smoker 11 (14.9) 21 (28.8)
Previous stroke 12 (16.2) 9 (12.3)
RACE score, median (IQR)c 7 (6-8) 7 (6-8)
NIHSS score, median (IQR)d 17 (14-21) 18 (14-22)
Onset or LTSW to door time, mean (SD), min 233.6 (106.3) 240.2 (130.7)
Primary/transferred 19/55 (25.7/74.3) 21/52 (28.8/71.2)
Unknown onset 15 (20.3) 7 (9.6)
ASPECTS at PSC, median (IQR) 10 (9-10) 10 (9-10)
Off-hours 40 (54.0) 50 (68.5)
Intravenous thrombolysis 37 (50.0) 39 (53.4)
Tandem occlusion 11 (14.9) 11 (15.1)
Endovascular treatment 74 (100) 64 (87.7)

Abbreviations: ASPECTS, Alberta Stroke Program Early Computed Tomography Score; DTAS, direct transfer to angiography suite; DTCT, direct transfer to computed tomography; IQR, interquartile range; LTSW, last time seen well; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; PSC, primary stroke center; RACE, Rapid Arterial Occlusion Evaluation.

a

Modified intention-to-treat population was defined as patients with large vessel occlusion. There were no significant differences between groups.

b

The mRS scores of functional disability range from 0 (no symptoms) to 6 (death). A score of 2 or lower indicates functional independence.

c

The RACE scale ranges from 0 to 9, with higher values indicating more severe stroke symptoms.

d

The NIHSS ranges from 0 to 42, with higher values indicating more severe stroke symptoms.